# Brad Younggren

> Brad Younggren is a Seattle physician, founder and healthcare operator whose career has moved from Army emergency medicine and disaster preparedness into portable diagnostics, virtual primary care and longevity research. After leading Circulate Health through a $12 million seed round and into a network of outpatient clinic partners, he was announced in August 2026 as president of Viome PRO following Viome’s acquisition of Circulate.

- **Role:** President of Viome PRO (announced August 2026); co-founder of Circulate Health
- **Organizations:** Viome Life Sciences, Circulate Health, Evergreen Emergency Services, EvergreenHealth, Washington State University Elson S. Floyd College of Medicine, 98point6, Cue Health, Shift Labs, Mobisante, United States Army, Eastside Research Associates, KardioGenics
- **Education:** B.A. in Political Science, University of California, Los Angeles, M.D., Uniformed Services University of the Health Sciences, Transitional internship and Emergency Medicine residency, Madigan Army Medical Center, Diploma in the Medical Care of Catastrophes, Royal Society of Apothecaries, London
- **Known for:** Awarded the Bronze Star and Combat Medical Badge for U.S. Army service in Iraq., Earned Fellow status in the American College of Emergency Physicians., Helped develop and commercialize mobile and digital-care products at Mobisante, Cue, Shift Labs and 98point6.

## Career timeline

- **1999-2003** — Completed a transitional internship and Emergency Medicine residency at Madigan Army Medical Center.
- **2003-2008** — Served as Associate Program Director in Madigan’s Department of Emergency Medicine.
- **2004-2005** — Deployed to Tall Afar, Iraq, as squadron surgeon for 2-14 Cavalry, 1-25 Infantry Division (Stryker), and received the Bronze Star and Combat Medical Badge.
- **2008-2010** — Served as Assistant Chief of Emergency Medicine at Madigan before leaving the Army.
- **2010-present** — Practiced emergency medicine with Evergreen Emergency Services; later served as Director of Emergency Ultrasound.
- **2011-present** — Held emergency preparedness and trauma leadership responsibilities at EvergreenHealth.
- **2012-2015** — Served as Chief Medical Officer of Mobisante, associated with the MobiUS smartphone-based ultrasound system.
- **2015-2017** — Held Chief Medical Officer roles at Shift Labs and Cue, and continued as a senior medical advisor to Shift Labs.
- **2017-2024** — Joined 98point6 as Chief Medical Officer and later became President and Chief Medical Officer for Care Innovation.
- **2020-present** — Served as an Assistant Professor at Washington State University’s Elson S. Floyd College of Medicine.
- **2024-2026** — Led Circulate Health as co-founder and CEO through its public launch, research program, clinic-network expansion and acquisition.
- **2025** — Circulate published a 42-participant clinical study and raised a $12 million seed round led by Khosla Ventures.
- **2026** — Viome acquired Circulate Health and announced Younggren as president of the new Viome PRO clinical group.

## Achievements

- Awarded the Bronze Star and Combat Medical Badge for U.S. Army service in Iraq.
- Earned Fellow status in the American College of Emergency Physicians.
- Helped develop and commercialize mobile and digital-care products at Mobisante, Cue, Shift Labs and 98point6.
- Led Circulate Health through a $12 million seed financing led by Khosla Ventures in 2025.
- Co-authored or contributed to peer-reviewed work in emergency medicine, disaster response, ultrasonography and clinical research.
- Announced as president of Viome PRO following Viome’s 2026 acquisition of Circulate Health.

## Latest updates

- **2026-08** — Viome Life Sciences acquired Circulate Health and announced Younggren as president of its newly formed Viome PRO clinical group.
- **2026-06** — Appeared on the Buck Institute podcast ‘We’re not getting any younger... yet.’ to discuss Circulate’s research and the economics of healthspan.
- **2026-05** — Featured on the ‘Going Beyond the Deal’ podcast about the infrastructure, clinic networks and data required to scale longevity services.
- **2025-07** — Circulate announced a $12 million seed round led by Khosla Ventures, with Seaside Ventures and CSC Ventures participating.
- **2025-05** — A Circulate and Buck Institute randomized, placebo-controlled study was published in Aging Cell; the small study reported biomarker changes and explicitly did not assess clinical outcomes.

## Links

- Website: https://circulate.health/
- LinkedIn: https://www.linkedin.com/in/younggren/
- Twitter/X: https://x.com/Younggren

---

Profile page: https://yespress.io/brad-younggren
Published by YesPress — https://yespress.io
Last updated: 2026-08-27